Technology

Technology

AI-Powered Discovery Platform


Advancements in AI technology are revolutionizing drug discovery at an unprecedented pace. We have built an AI-driven discovery platform and applied it extensively to the design and development of candidate therapeutics. 
Leveraging this platform, we have accelerated multiple platform enhancements and pipeline innovation: 

Platform Enhancement: Our novel synthetic RNA structures not only enhance target protein expression and reduce mutation risks, but also enable tissue-specific translation, allowing therapies to be precisely directed to target tissues such as the liver or tumors. 

Multivalent RNA Vaccine Design (e.g., JCXH-110): We use AI-driven sequence optimization, to design candidate vaccines,programing single-strand RNA constructs to encode fusion proteins incorporating 2–3 distinct viral antigens and multimerization domains. This is expected to elicit broad immune protection against multiple viral strains with a single dose. 

 


Business license

Statement

SEO